| 30.98 -0.01 (-0.03%) | 10-24 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 36.27 | 1-year : | 42.37 |
| Resists | First : | 31.05 | Second : | 36.27 |
| Pivot price | 30.91  |
|||
| Supports | First : | 30.81 | Second : | 30.67 |
| MAs | MA(5) : | 30.97 |
MA(20) : | 30.89 |
| MA(100) : | 26.89 |
MA(250) : | 0 | |
| MACD | MACD : | 0.1  |
Signal : | 0.2 |
| %K %D | K(14,3) : | 66.4 |
D(3) : | 68.6 |
| RSI | RSI(14): 80 | |||
| 52-week | High : | 31.05 | Low : | 15.09 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ PETQ ] has closed below upper band by 16.4%. Bollinger Bands are 93.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 42 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 31.01 - 31.16 | 31.16 - 31.29 |
| Low: | 30.61 - 30.79 | 30.79 - 30.94 |
| Close: | 30.72 - 30.99 | 30.99 - 31.22 |
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as distributes third-party branded medications. It also provides OTC medications and supplies primarily within the flea and tick control, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dental treats and nutritional supplements, which comprise hip and joint, vitamins, and skin and coat products. The company provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PetLock, Heart Shield Plus, TruProfen, Betsy Farms, PetAction, Minties, Vera, and Delightibles brands. In addition, the company offers a suite of services at 2,900 community clinics and wellness centers hosted at pet retailers across 42 states, including diagnostic tests, vaccinations, prescription medications, microchipping, and wellness checks. It operates through approximately 60,000 points of distribution across veterinarian, retail, and e-commerce channels. The company was founded in 2010 and is headquartered in Eagle, Idaho.
Fri, 25 Oct 2024
PetIQ, Inc. Announces Successful Completion of Acquisition by Bansk Group - Yahoo Finance
Fri, 25 Oct 2024
PetIQ, Inc. Announces Successful Completion of Acquisition by Bansk Group - StockTitan
Thu, 05 Sep 2024
ZTS: 3 Pet Care Stocks With Tail-Wagging Potential - StockNews.com
Wed, 07 Aug 2024
PetIQ, Inc. Enters into Definitive Agreement to be Acquired by Bansk Group - StockTitan
Wed, 07 Aug 2024
PetIQ’s stock skyrockets after $1.5 billion sale to Bansk Group - MarketWatch
Thu, 14 Mar 2024
PetIQ, Inc. Celebrates Expansion of Minties® Dental Treats - GlobeNewswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
| Shares Out | 30 (M) |
| Shares Float | 24 (M) |
| Held by Insiders | 7 (%) |
| Held by Institutions | 102 (%) |
| Shares Short | 1,020 (K) |
| Shares Short P.Month | 1,140 (K) |
| EPS | 0.37 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 8.71 |
| Profit Margin | 1.1 % |
| Operating Margin | 8.6 % |
| Return on Assets (ttm) | 4.8 % |
| Return on Equity (ttm) | 5.5 % |
| Qtrly Rev. Growth | 4.5 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 38.08 |
| EBITDA (p.s.) | 3.42 |
| Qtrly Earnings Growth | 52.2 % |
| Operating Cash Flow | 20 (M) |
| Levered Free Cash Flow | 2 (M) |
| PE Ratio | 83.72 |
| PEG Ratio | 0.6 |
| Price to Book value | 3.55 |
| Price to Sales | 0.81 |
| Price to Cash Flow | 45.45 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|